UBX Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-03-26 | Nguyen Alexander Hieu | officer: Chief Legal Officer | 30,000 | A-Award | A | 30,000 | 1.62 | 48,600.00 |
| 2024-03-26 | Nguyen Alexander Hieu | officer: Chief Legal Officer | 25,104 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2024-02-02 | Ghosh Anirvan | director, officer: Chief Executive Officer | 78,746 | S-Sale | D | 680 | 1.71 | 1,163.00 |
| 2024-01-30 | Ghosh Anirvan | director, officer: Chief Executive Officer | 79,426 | S-Sale | D | 1,183 | 1.71 | 2,023.00 |
| 2023-11-02 | Ghosh Anirvan | director, officer: Chief Executive Officer | 80,609 | S-Sale | D | 589 | 1.83 | 1,078.00 |
| 2023-10-30 | Ghosh Anirvan | director, officer: Chief Executive Officer | 81,198 | S-Sale | D | 1,024 | 1.90 | 1,946.00 |
| 2023-09-14 | Ghosh Anirvan | director, officer: Chief Executive Officer | 82,222 | S-Sale | D | 1,246 | 2.47 | 3,078.00 |
| 2023-08-02 | Ghosh Anirvan | director, officer: Chief Executive Officer | 83,468 | S-Sale | D | 581 | 2.94 | 1,708.00 |
| 2023-07-31 | Ghosh Anirvan | officer: Chief Executive Officer | 84,049 | S-Sale | D | 1,020 | 2.86 | 2,917.00 |
| 2023-06-26 | Ghosh Anirvan | director, officer: Chief Executive Officer | 85,069 | S-Sale | D | 1,177 | 3.20 | 3,766.00 |
| 2023-06-23 | Samuels Camille D | director | 6,000 | A-Award | A | 6,000 | 3.25 | 19,500.00 |
| 2023-06-23 | BERNS PAUL L | director | 6,000 | A-Award | A | 6,000 | 3.25 | 19,500.00 |
| 2023-06-23 | O'Neill Gilmore Neil | director | 6,000 | A-Award | A | 6,000 | 3.25 | 19,500.00 |
| 2023-06-23 | Roberts Margo R | director | 6,000 | A-Award | A | 6,000 | 3.25 | 19,500.00 |
| 2023-06-23 | Samar Michael P. | director | 6,000 | A-Award | A | 6,000 | 3.25 | 19,500.00 |
| 2023-06-23 | Leonard Keith R | director | 6,000 | A-Award | A | 6,000 | 3.25 | 19,500.00 |
| 2023-06-23 | David Nathaniel E | director | 6,000 | A-Award | A | 6,000 | 3.25 | 19,500.00 |
| 2023-06-14 | Ghosh Anirvan | director, officer: Chief Executive Officer | 86,246 | S-Sale | D | 1,212 | 3.39 | 4,109.00 |
| 2023-05-11 | Sullivan Lynne Marie | officer: See Remarks | 40,000 | A-Award | A | 40,000 | 2.77 | 110,800.00 |
| 2023-05-11 | Sullivan Lynne Marie | officer: See Remarks | 24,000 | A-Award | A | 24,000 | 2.77 | 66,480.00 |
| 2023-05-11 | Sullivan Lynne Marie | officer: See Remarks | 20,000 | A-Award | A | 20,000 | 2.77 | 55,400.00 |
| 2023-05-11 | Sullivan Lynne Marie | officer: See Remarks | 12,333 | A-Award | A | 12,333 | 2.77 | 34,162.00 |
| 2023-05-11 | Sullivan Lynne Marie | officer: See Remarks | 0 | D-Return | D | 24,000 | 99.60 | 2,390,400.00 |
| 2023-05-11 | Sullivan Lynne Marie | officer: See Remarks | 0 | D-Return | D | 12,333 | 41.80 | 515,519.00 |
| 2023-05-11 | Sullivan Lynne Marie | officer: See Remarks | 0 | D-Return | D | 20,000 | 10.60 | 212,000.00 |
| 2023-05-11 | Nguyen Alexander Hieu | officer: See Remarks | 40,000 | A-Award | A | 40,000 | 2.77 | 110,800.00 |
| 2023-05-11 | Nguyen Alexander Hieu | officer: See Remarks | 18,332 | A-Award | A | 18,332 | 2.77 | 50,780.00 |
| 2023-05-11 | Nguyen Alexander Hieu | officer: See Remarks | 2,083 | A-Award | A | 2,083 | 2.77 | 5,770.00 |
| 2023-05-11 | Nguyen Alexander Hieu | officer: See Remarks | 0 | D-Return | D | 2,083 | 41.80 | 87,069.00 |
| 2023-05-11 | Nguyen Alexander Hieu | officer: See Remarks | 0 | D-Return | D | 18,332 | 10.60 | 194,319.00 |
| 2023-05-11 | Ghosh Anirvan | director, officer: Chief Executive Officer | 135,000 | A-Award | A | 135,000 | 2.77 | 373,950.00 |
| 2023-05-11 | Ghosh Anirvan | director, officer: Chief Executive Officer | 56,666 | A-Award | A | 56,666 | 2.77 | 156,965.00 |
| 2023-05-11 | Ghosh Anirvan | director, officer: Chief Executive Officer | 29,000 | A-Award | A | 29,000 | 2.77 | 80,330.00 |
| 2023-05-11 | Ghosh Anirvan | director, officer: Chief Executive Officer | 24,999 | A-Award | A | 24,999 | 2.77 | 69,247.00 |
| 2023-05-11 | Ghosh Anirvan | director, officer: Chief Executive Officer | 15,000 | A-Award | A | 15,000 | 2.77 | 41,550.00 |
| 2023-05-11 | Ghosh Anirvan | director, officer: Chief Executive Officer | 0 | D-Return | D | 24,999 | 29.40 | 734,971.00 |
| 2023-05-11 | Ghosh Anirvan | director, officer: Chief Executive Officer | 0 | D-Return | D | 29,000 | 41.80 | 1,212,200.00 |
| 2023-05-11 | Ghosh Anirvan | director, officer: Chief Executive Officer | 0 | D-Return | D | 15,000 | 59.75 | 896,250.00 |
| 2023-05-11 | Ghosh Anirvan | director, officer: Chief Executive Officer | 0 | D-Return | D | 56,666 | 10.60 | 600,660.00 |
| 2023-05-02 | Ghosh Anirvan | director, officer: Chief Executive Officer | 87,458 | S-Sale | D | 588 | 2.17 | 1,276.00 |
| 2023-05-01 | Ghosh Anirvan | director, officer: Chief Executive Officer | 88.046 | S-Sale | D | 1,020 | 2.15 | 2,193.00 |
| 2023-03-31 | Ghosh Anirvan | director, officer: Chief Executive Officer | 89,066 | S-Sale | D | 1,959 | 1.70 | 3,330.00 |
| 2023-03-31 | Dananberg Jamie | officer: Chief Medical Officer | 62,817 | S-Sale | D | 420 | 1.70 | 714.00 |
| 2023-03-14 | Dananberg Jamie | officer: Chief Medical Officer | 63,237 | S-Sale | D | 1,005 | 4.00 | 4,020.00 |
| 2023-03-14 | Ghosh Anirvan | director, officer: Chief Executive Officer | 91,025 | S-Sale | D | 1,210 | 4.00 | 4,840.00 |
| 2023-02-02 | Dananberg Jamie | officer: Chief Medical Officer | 64,242 | S-Sale | D | 863 | 4.84 | 4,177.00 |
| 2023-02-02 | Ghosh Anirvan | director, officer: Chief Executive Officer | 92,235 | S-Sale | D | 2,573 | 4.84 | 12,453.00 |
| 2023-01-30 | Ghosh Anirvan | director, officer: Chief Executive Officer | 94,808 | S-Sale | D | 1,140 | 4.45 | 5,073.00 |
| 2022-12-14 | Ghosh Anirvan | officer: Chief Executive Officer | 95,948 | S-Sale | D | 1,274 | 2.85 | 3,631.00 |
| 2022-12-14 | Dananberg Jamie | officer: Chief Medical Officer | 65,105 | S-Sale | D | 1,016 | 2.85 | 2,896.00 |
| 2022-11-18 | Ghosh Anirvan | officer: Chief Executive Officer | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2022-11-18 | Dananberg Jamie | officer: Chief Medical Officer | 65,000 | A-Award | A | 65,000 | 0.00 | 0.00 |
| 2022-11-18 | Nguyen Alexander Hieu | officer: See Remarks | 65,000 | A-Award | A | 65,000 | 0.00 | 0.00 |
| 2022-11-18 | Sullivan Lynne Marie | officer: CFO & Head of Corp. Dev. | 80,000 | A-Award | A | 80,000 | 0.00 | 0.00 |
| 2022-05-15 | Sullivan Lynne Marie | officer: CFO & Head of Corp. Dev. | 33,009 | J-Other | A | 925 | 6.89 | 6,373.00 |
| 2022-11-03 | Ghosh Anirvan | officer: Chief Executive Officer | 97,222 | S-Sale | D | 1,099 | 2.40 | 2,638.00 |
| 2022-09-14 | Ghosh Anirvan | director, officer: Chief Executive Officer | 983,210 | S-Sale | D | 13,706 | 0.48 | 6,579.00 |
| 2022-09-14 | Dananberg Jamie | officer: Chief Medical Officer | 661,213 | S-Sale | D | 10,923 | 0.48 | 5,243.00 |
| 2022-08-01 | Ghosh Anirvan | officer: Chief Executive Officer | 996,916 | S-Sale | D | 10,446 | 0.67 | 6,999.00 |
| 2022-06-27 | Dananberg Jamie | officer: Chief Medical Officer | 672,136 | S-Sale | D | 4,398 | 0.59 | 2,595.00 |
| 2022-06-27 | Ghosh Anirvan | officer: Chief Executive Officer | 1,007,362 | S-Sale | D | 12,149 | 0.59 | 7,168.00 |
| 2022-06-24 | O'Neill Gilmore Neil | director: | 25,000 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2022-06-24 | Samuels Camille D | director: | 25,000 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2022-06-24 | Samuels Camille D | director | 25,000 | A-Award | A | 25,000 | 0.59 | 14,750.00 |
| 2022-06-24 | Roberts Margo R | director: | 25,000 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2022-06-24 | Roberts Margo R | director | 25,000 | A-Award | A | 25,000 | 0.59 | 14,750.00 |
| 2022-06-24 | Leonard Keith R | director: | 25,000 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2022-06-24 | Leonard Keith R | director | 25,000 | A-Award | A | 25,000 | 0.59 | 14,750.00 |
| 2022-06-24 | BERNS PAUL L | director: | 25,000 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2022-06-24 | BERNS PAUL L | director | 25,000 | A-Award | A | 25,000 | 0.59 | 14,750.00 |
| 2022-06-24 | Samar Michael P. | director: | 2,055 | A-Award | A | 2,055 | 0.00 | 0.00 |
| 2022-06-24 | Samar Michael P. | director | 2,055 | A-Award | A | 2,055 | 0.59 | 1,212.00 |
| 2022-06-24 | David Nathaniel E | director: | 25,000 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2022-06-24 | David Nathaniel E | director | 25,000 | A-Award | A | 25,000 | 0.59 | 14,750.00 |
| 2022-06-21 | Dananberg Jamie | officer: Chief Medical Officer | 676,534 | S-Sale | D | 3,697 | 0.62 | 2,292.00 |
| 2022-06-14 | Ghosh Anirvan | officer: Chief Executive Officer | 1,019,511 | F-InKind | D | 12,683 | 0.63 | 7,990.00 |
| 2022-06-14 | Dananberg Jamie | officer: Chief Medical Officer | 680,231 | F-InKind | D | 10,530 | 0.63 | 6,634.00 |
| 2022-05-25 | Samar Michael P. | director: | 50,000 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2022-05-25 | Samar Michael P. | director | 50,000 | A-Award | A | 50,000 | 0.76 | 38,000.00 |
| 2022-05-25 | Samar Michael P. | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-05-02 | Ghosh Anirvan | officer: Chief Executive Officer | 1,032,194 | F-InKind | D | 7,729 | 0.88 | 6,802.00 |
| 2022-03-31 | Ghosh Anirvan | officer: Chief Executive Officer | 1,039,923 | F-InKind | D | 14,472 | 1.14 | 16,498.00 |
| 2022-03-31 | Dananberg Jamie | officer: Chief Medical Officer | 690,761 | F-InKind | D | 4,188 | 1.14 | 4,774.00 |
| 2022-03-14 | Ghosh Anirvan | officer: Chief Executive Officer | 1,054,395 | F-InKind | D | 9,272 | 0.88 | 8,159.00 |
| 2022-03-14 | Dananberg Jamie | officer: Chief Medical Officer | 694,949 | F-InKind | D | 10,581 | 0.88 | 9,311.00 |
| 2022-02-09 | Dananberg Jamie | officer: Chief Medical Officer | 705,530 | A-Award | A | 45,833 | 0.00 | 0.00 |
| 2022-02-09 | Dananberg Jamie | officer: Chief Medical Officer | 183,333 | A-Award | A | 183,333 | 1.06 | 194,333.00 |
| 2022-02-09 | Nguyen Alexander Hieu | officer: See Remarks | 183,333 | A-Award | A | 183,333 | 1.06 | 194,333.00 |
| 2022-02-09 | Nguyen Alexander Hieu | officer: See Remarks | 51,041 | A-Award | A | 45,833 | 0.00 | 0.00 |
| 2022-02-09 | Sullivan Lynne Marie | officer: CFO & Head of Corp. Dev. | 326,785 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2022-02-09 | Sullivan Lynne Marie | officer: CFO & Head of Corp. Dev. | 200,000 | A-Award | A | 200,000 | 1.06 | 212,000.00 |
| 2022-02-09 | Ghosh Anirvan | director, officer: Chief Executive Officer | 1,063,667 | A-Award | A | 141,667 | 0.00 | 0.00 |
| 2022-02-09 | Ghosh Anirvan | director, officer: Chief Executive Officer | 566,667 | A-Award | A | 566,667 | 1.06 | 600,667.00 |
| 2021-12-14 | Dananberg Jamie | officer: Chief Medical Officer | 659,697 | F-InKind | D | 10,614 | 1.63 | 17,301.00 |
| 2021-03-30 | Dananberg Jamie | officer: Chief Medical Officer | 670,311 | F-InKind | D | 40,564 | 2.95 | 119,664.00 |
| 2021-06-24 | Nguyen Alexander Hieu | officer: See Remarks | 20,833 | A-Award | A | 20,833 | 4.18 | 87,082.00 |
| 2021-06-24 | Nguyen Alexander Hieu | officer: See Remarks | 5,208 | A-Award | A | 5,208 | 0.00 | 0.00 |
| 2021-06-24 | O'Neill Gilmore Neil | director | 13,425 | A-Award | A | 13,425 | 4.18 | 56,116.00 |
| 2021-06-24 | Roberts Margo R | director | 25,000 | A-Award | A | 25,000 | 4.18 | 104,500.00 |
| 2021-06-24 | David Nathaniel E | director | 11,918 | A-Award | A | 11,918 | 4.18 | 49,817.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
